Niki BioSolutions, Inc.(NIKI)

Biotechnology · Princeton, NJ

$4.78+0.05 (+1.08%)

Delayed quote: Oct 6, 2026, 12:38 PM EDT

EV/Sales Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/Sales ratio is N/A as of 2026-10-06T16:43:37.392Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:43:37.392Z.

Quote observation: 2026-10-06T16:38:53.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 389,228
Total debt · period ending 2025-12-31: 3,442,928
Cash · period ending 2025-12-31: 3,452,891
TTM revenue · period ending 2025-12-31: N/A

FMP input reference: 05f4ae4a030aaca39f2691a5695262832c6d48704f11c5316ed8238ac0b3761e

EV/EBITDA|P/S Ratio|Revenue|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NIKI EV/Sales Ratio Metrics

EV/SALES RATIO

N/A

NIKI Competitors' EV/Sales Ratio

NIKI

Niki BioSolutions, Inc.

Current

Market Cap

$389228.00

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SPRC

SciSparc Ltd.

vs NIKI

Market Cap

$244081.00

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCWB

HCW Biologics Inc.

vs NIKI

Market Cap

$559702.00

EV/Sales Ratio

0.95x

TTM Avg

22.73x

3Y Avg

233.34x

5Y Avg

409.95x

SLXN

Silexion Therapeutics Ltd.

vs NIKI

Market Cap

$108604.00

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PBM

Psyence Biomedical Ltd.

vs NIKI

Market Cap

$95000.00

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDT

CDT Equity Inc.

vs NIKI

Market Cap

$675543.00

EV/Sales Ratio

0.67x

TTM Avg

1.27x

3Y Avg

1.27x

5Y Avg

1.27x

PRFX

PRF Technologies Ltd.

vs NIKI

Market Cap

$71496.00

EV/Sales Ratio

N/A

TTM Avg

159.76x

3Y Avg

159.76x

5Y Avg

159.76x

AKAN

Akanda Corp.

vs NIKI

Market Cap

$62628.00

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

vs NIKI

Market Cap

$30509.00

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NIVF

NewGenIvf Group Limited

vs NIKI

Market Cap

$6210.00

EV/Sales Ratio

N/A

TTM Avg

7806.53x

3Y Avg

7806.53x

5Y Avg

7806.53x

NAME	MARKET CAP	EV/SALES RATIO	TTM	3Y	5Y
Niki BioSolutions, Inc. (NIKI)	$389228.00	N/A	N/A	N/A	N/A
SciSparc Ltd. (SPRC)vs ›	$244081.00	N/A	N/A	N/A	N/A
HCW Biologics Inc. (HCWB)vs ›	$559702.00	0.95x	22.73x	233.34x	409.95x
Silexion Therapeutics Ltd. (SLXN)vs ›	$108604.00	N/A	N/A	N/A	N/A
Psyence Biomedical Ltd. (PBM)vs ›	$95000.00	N/A	N/A	N/A	N/A
CDT Equity Inc. (CDT)vs ›	$675543.00	0.67x	1.27x	1.27x	1.27x
PRF Technologies Ltd. (PRFX)vs ›	$71496.00	N/A	159.76x	159.76x	159.76x
Akanda Corp. (AKAN)vs ›	$62628.00	N/A	N/A	N/A	N/A
Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs ›	$30509.00	N/A	N/A	N/A	N/A
NewGenIvf Group Limited (NIVF)vs ›	$6210.00	N/A	7806.53x	7806.53x	7806.53x

Understanding EV/Sales

Enterprise Value (EV) = Market Cap + Total Debt - Cash

Sales = Total Revenue (TTM)

EV/Sales is commonly used because:

It works for unprofitable companies where P/E doesn't apply
Revenue is harder to manipulate than earnings
It supports comparisons across companies at different profitability stages
It is frequently used for software and other revenue-growth-focused companies

Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.

EV/Sales Ratio Formula & Definition

EV/Sales = Enterprise Value / Revenue (TTM)

Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/EBITDA P/S Ratio Revenue All Metrics